
Addus HomeCare (ADUS) Stock Forecast & Price Target
Addus HomeCare (ADUS) Analyst Ratings
Bulls say
Addus HomeCare Corp is poised for strong future growth, driven by a healthy expansion of its Hospice segment, which reported a significant year-over-year revenue increase of 7.8%, with expectations to reach the high end of 5-7% growth in the upcoming periods. The Home Health segment continues to show positive momentum with a 1.6% year-over-year revenue increase, and management anticipates a growth outlook for Personal Care Services at the high end of 3-5% due to easing Medicaid disruptions and normalization of admissions. Furthermore, consensus estimates for 2025 reflect a notable uptick, with revenue, EBITDA, and EPS expectations rising by 11%, 15%, and 8% respectively, indicating a solid market confidence in Addus's strategic initiatives and acquisition opportunities.
Bears say
Addus HomeCare Corp has experienced a decline in key operational metrics, with Home Health volumes showing a negative same-store growth of -3.2% year-over-year and new admissions decreasing by -6.2%. Additionally, the company's financial performance is under pressure, evidenced by total visits in Home Health falling by -4.2% year-over-year and a reduction in adjusted EBITDA estimates for 2025-2027, reflecting a downward trend in profitability. Furthermore, expectations of gross margin compression in the upcoming quarter, driven by a mix shift from the inclusion of Gentiva and seasonal payroll effects, further exacerbate the company's weak financial outlook.
This aggregate rating is based on analysts' research of Addus HomeCare and is not a guaranteed prediction by Public.com or investment advice.
Addus HomeCare (ADUS) Analyst Forecast & Price Prediction
Start investing in Addus HomeCare (ADUS)
Order type
Buy in
Order amount
Est. shares
0 shares